- Filed
- May 14, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 10, 2026 | 5.5M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 3.88M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 948.11K sh |
| Capex | Q1 2026 · Mar 31, 2026 | $38K |
| Capex | Q1 2026 · Mar 31, 2025 | $21K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$5.57M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$4.67M |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $35K |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $88K |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $36.61M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $10.4M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $42.76M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $12.5M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $9.5M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$1.08M |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $2.39M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $3.66M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $2.83M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $4.24M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $44.21M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $15.32M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $45.59M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $16.74M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.43 |
| Eps Diluted restated | Q1 2026 · Mar 31, 2025 | −$3.55 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.43 |
| Eps Basic restated | Q1 2026 · Mar 31, 2025 | −$3.55 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $1.39M |
| Sga Expense | Q1 2026 · Mar 31, 2025 | $895K |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $1.01M |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $1.19M |
| Net Income | Q1 2026 · Mar 31, 2026 | −$1.66M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$3.37M |
| Operating Income | Q1 2026 · Mar 31, 2026 | −$1.85M |
| Operating Income | Q1 2026 · Mar 31, 2025 | −$3.61M |
| Gross Profit | Q1 2026 · Mar 31, 2026 | $1.1M |
| Gross Profit | Q1 2026 · Mar 31, 2025 | $93K |
| Cost Of Revenue | Q1 2026 · Mar 31, 2026 | $1.99M |
| Cost Of Revenue | Q1 2026 · Mar 31, 2025 | $250K |